Effect of Aspirin on Pre-eclampsia and Fetal Growth Restriction in Obese Pregnant Women: A Randomized Controlled Clinical Trial

Vanda, Raziyeh; Aramesh, Shahintaj; Sadeghian, Mehdi; Ghatee, Mohammad Amin; Ghaffari, Parvin

doi:10.52547/jccs.1.4.159

Cited by 1 publication

(1 citation statement)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A study by Abdi et al declared that the use of aspirin reduced the incidence of complications such as IUGR (20). Vanda et al showed that the use of aspirin (80 mg) reduced maternal and fetal complications in PE mothers (21). The present study also suggested that increasing aspirin dosage would prevent complications such as IUGR and IUFD.…”

Section: Discussionsupporting

confidence: 63%

Effect of Aspirin Dose on Preeclampsia Prevention and Fetal-maternal Complications: A Randomized Clinical Trial

Chamani

Shahrabi

Malmir

et al. 2021

Jundishapur J Chronic Dis Care

View full text Add to dashboard Cite

Background: Preeclampsia (PE) is a disease characterized by abnormalities in the placenta and endothelial cells. The pathogenesis is not fully understood; however, aspirin prescription can be effective to treat the disease and prevent fetal developmental disorders. Methods: This study was performed as a clinical trial in Shahid Akbrabadi Hospital in Tehran city. Eighty patients participated in two groups (n = 40). The first group of patients received the dose of 80 mg, and the second group received the dose of 160 mg aspirin. Then, the fetal-maternal and treatment process complications were examined in the patients. Results: The results showed that the incidence of fetal-maternal complications, including intrauterine growth restriction (IUGR) and intrauterine fetal death (IUFD) was lower in patients treated with 160 mg aspirin than in the other group, but this difference was not statistically significant (P-value > 0.05). Aspirin complications such as bleeding were more in the second group than in the first one (P-value < 0.05). Conclusions: Although the increasing dose of aspirin reduces fetal-maternal complications in PE patients, the problems such as aspirin-induced bleeding should be considered.

show abstract

Section: Discussionsupporting

confidence: 63%